SARS-CoV-2 Infection and Coronavirus Disease (COVID-19) Clinical Data: A Review of the Literature

Nicolas Padilla-Raygoza^1*, Cuauhtemoc Sandoval- Salazar², Vicente Beltran-Campos³, Xochitl Sofia Ramirez-Gomez³, María de Jesus Gallardo-Luna⁴, Efrain Navarro-Olivos⁴ and Daniel Alberto Diaz-Martinez⁴

¹School of Medicine, University of Celaya, Celaya, México, CP 38080

²Department of Nursing and Obstetrics, Division of Health Sciences and Engineering, Campus Celaya-Salvatierra, University of Guanajuato, Celaya, México, CP 38060

³Clinical Nursing, Division of Health Sciences and Engineering, Campus Celaya-Salvatierra, University of Guanajuato, Celaya, México, CP 38140

⁴Institute of Public Health from Guanajuato State, Guanajuato, México CP36,000

Corresponding Author E-mail: npadilla@udec.edu.mx

Abstract: The aim was to describe the clinical data from patients with confirmed cases of COVID-19 and clinical data of patients with pneumonia by the same virus. It was selected articles on clinical data from patients with COVID-19 and pneumonia by SARS-CoV-2 in pubmed, embase and google schoolar. It was described the clinical data of patients with COVID-19 from 3 studies with 1,078 patients. The main clinical data for COVID-19 were cough 60.4%, fever 40.9%, and production of sputum 26.0%. For pneumonia by SARS-CoV-2, was described clinical data from 495 patients from 5 studies, were fever 77.4%, cough 68.9%, and myoarthralgia 49.9%. In children with COVID-19 was reported cough 48.5%, pharyngeal erythema 46,2%, and fever 41.5%. To use only clinical data to submit patients to RT-PCR test is not good, because many infected patients have not clinical data (asymptomatic carriers) or they did not reported the main clinical data as fever, cough or myoarthralgia.

Keywords: COVID-19; Pneumonia; Signs; Symptoms; SARS-CoV-2

[ HTML Full Text]

Back to TOC